FDA Adverse Event Injury Summary report: N

T:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY

MDR report key: 16941095 · Received May 16, 2023

Report

Report Number
3013756811-2023-65826
Event Type
Injury
Date Received
May 16, 2023
Date of Event
April 23, 2023
Report Date
May 16, 2023
Manufacturer
TANDEM DIABETES CARE
Product Code
QFG
UDI-DI
00850006613793
PMA / PMN Number
K201214
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. USE ERROR. PER THE USER GUIDE: WARNING - NEVER FILL YOUR TUBING WHILE YOUR INFUSION SET IS CONNECTED TO YOUR BODY. ALWAYS ENSURE THAT THE INFUSION SET IS DISCONNECTED FROM YOUR BODY BEFORE FILLING THE TUBING. FAILURE TO DISCONNECT YOUR INFUSION SET FROM YOUR BODY BEFORE FILLING THE TUBING CAN RESULT IN OVER DELIVERY OF INSULIN. H3 OTHER TEXT : DEVICE NOT RETURNED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE CUSTOMER INADVERTENTLY PERFORMED THE LOAD SEQUENCE WHILE CONNECTED TO THE SITE. IT WAS REPORTED THAT THE CUSTOMER WENT TO THE EMERGENCY ROOM (ER) WITH A BLOOD GLUCOSE (BG) LEVEL OF 120-185 MG/DL. CUSTOMER CONSUMED CARBOHYDRATES AND GLUCAGON TO ADDRESS THE BG. CUSTOMER WAS OBSERVED ONLY IN THE ER AND DISCHARGED LATER THE SAME DAY WITH THE ISSUE RESOLVED AND NO PERMANENT DAMAGE. REPORTEDLY, CUSTOMER CONTINUED TO USE THE PUMP FOR INSULIN THERAPY. RECOMMENDATION WAS MADE TO CONSULT WITH A HEALTHCARE PROVIDER REGARDING DIABETES MANAGEMENT. TANDEM TECHNICAL SUPPORT EDUCATED THE CUSTOMER TO NOT BE CONNECTED TO THE PUMP DURING THE FILL TUBING PROCESS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2184263 T:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY ALTERNATE CONTROLLER ENABLED INFUSION PUMP QFG TANDEM DIABETES CARE 1000354 00850006613793

Patients

Seq Age Sex Outcome Treatment
1 74 YR Female INSULIN: NOVOLOG / NOVORAPID